Dr. Ghannoum has studied fungus for over forty years, and is widely considered the leading expert on medically important fungus. He lectures at many institutions, such as the National Institutes of Health, on the microbiome and his breakthrough research in the probiotic space. He is also the scientist who named the mycobiome, our body’s native fungal community. He coined the term in 2010, after identifying 101 different fungal species that live in the mouth.

After making the breakthrough discovery that bad bacteria and bad fungus work together to create digestive plaque (a discovery covered globally by outlets such as CBS News, Scientific American, Forbes and USA Today), Dr. Ghannoum realized that probiotics currently available had not been engineered to specifically address the role fungus plays in digestive health. As a result – he created BIOHM: The first complete probiotic that addresses the gut’s total microbiome of both bacteria and fungus.

During his career, he has published several books on fungus and over 350 peer-reviewed scientific papers. His work has been cited almost 18,000 times by other scientists. [For more information on Dr. Ghannoum’s research, Click here.] He has received over $25 million in funding for his research from the National Institutes of Health and has raised over $20 million in venture capital for several successful biotechnology companies. Dr. Ghannoum has also conducted many pre-clinical studies behind some of the largest anti-fungal drugs in the world and continues to guide some of the largest global pharmaceutical companies as they develop drugs related to treating fungal disease.